| Literature DB >> 29425486 |
Yi-Jang Lin1, Kevin M Haigis2.
Abstract
K-Ras is the undisputed champion of oncogenes, yet our ability to interfere with its oncogenic function is hampered by insufficient mechanistic understanding. In this issue of Cell, Ambrogio and colleagues connect the ability of K-Ras to dimerize to the ability of wild-type K-Ras to limit the oncogenic properties of the mutant.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29425486 DOI: 10.1016/j.cell.2018.01.019
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582